|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/00 | (2006.01) | ||
| C07K 14/705 | (2006.01) |
| (11) | Number of the document | 2116259 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09168970.3 |
| Date of filing the European patent application | 2002-05-20 | |
| (97) | Date of publication of the European application | 2009-11-11 |
| (45) | Date of publication and mention of the grant of the patent | 2012-01-25 |
| (46) | Date of publication of the claims translation | 2012-05-25 |
| (30) | Number | Date | Country code |
| 293343 P | 2001-05-24 | US |
| (72) |
Rixon, Mark W, US
Gross, Jane A, US
|
| (73) |
ZymoGenetics, Inc.,
1201 Eastlake Avenue East, Seattle, Washington 98102,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | TACI-imunoglobulino sulieti baltymai |
| TACI-immunoglobulin fusion proteins |
| Payment date | Validity (years) | Amount | |
| 2021-04-21 | 347.00 EUR |